Correlation Between MYR and Telomir Pharmaceuticals,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MYR and Telomir Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MYR and Telomir Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MYR Group and Telomir Pharmaceuticals, Common, you can compare the effects of market volatilities on MYR and Telomir Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MYR with a short position of Telomir Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of MYR and Telomir Pharmaceuticals,.

Diversification Opportunities for MYR and Telomir Pharmaceuticals,

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between MYR and Telomir is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding MYR Group and Telomir Pharmaceuticals, Commo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telomir Pharmaceuticals, and MYR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MYR Group are associated (or correlated) with Telomir Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telomir Pharmaceuticals, has no effect on the direction of MYR i.e., MYR and Telomir Pharmaceuticals, go up and down completely randomly.

Pair Corralation between MYR and Telomir Pharmaceuticals,

Given the investment horizon of 90 days MYR Group is expected to under-perform the Telomir Pharmaceuticals,. But the stock apears to be less risky and, when comparing its historical volatility, MYR Group is 2.32 times less risky than Telomir Pharmaceuticals,. The stock trades about -0.04 of its potential returns per unit of risk. The Telomir Pharmaceuticals, Common is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  420.00  in Telomir Pharmaceuticals, Common on November 20, 2024 and sell it today you would earn a total of  9.00  from holding Telomir Pharmaceuticals, Common or generate 2.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

MYR Group  vs.  Telomir Pharmaceuticals, Commo

 Performance 
       Timeline  
MYR Group 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days MYR Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, MYR is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Telomir Pharmaceuticals, 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Telomir Pharmaceuticals, Common are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Telomir Pharmaceuticals, displayed solid returns over the last few months and may actually be approaching a breakup point.

MYR and Telomir Pharmaceuticals, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MYR and Telomir Pharmaceuticals,

The main advantage of trading using opposite MYR and Telomir Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MYR position performs unexpectedly, Telomir Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telomir Pharmaceuticals, will offset losses from the drop in Telomir Pharmaceuticals,'s long position.
The idea behind MYR Group and Telomir Pharmaceuticals, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing